Skip to main content
Premium Trial:

Request an Annual Quote

BD Completes Accuri Cytometers Buy

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today announced the completion of its acquisition of Accuri Cytometers for an undisclosed amount.

Based in Ann Arbor, Mich., Accuri develops personal flow cytometers. The acquisition, announced last month during BD's first quarter earnings release, helps expand the use of flow cytometry technology in regions where ease of use and affordability are critical, BD said.

"The acquisition … complements and broadens BD's offerings for life scientists by making flow cytometry more accessible to a wider audience of scientists and clinicians," William Rhodes, president of BD Biosciences, said in a statement.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.